Park Square has placed Daniel Elgort, Ph.D. as Chief Data & Analytics Officer at Character Biosciences.
Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, today announced the appointment of Daniel Elgort, Ph.D. as Chief Data & Analytics Officer. Dr. Elgort will lead Character’s Data Science and Engineering teams, building on the company’s platform for integrating clinical, imaging, and genetic data. He has more than 20 years of experience in real-world multi-modality data analysis and in building high-performing data science organizations. He previously served as Chief Data & Analytics Officer at Aster Insights, which was recently acquired by Zephyr AI.
